The viewpoint of the committee and the algorithm developed are, in many ways, very similar to the article previously published by this author on this topic. [3] The current commentary will review the ...

Purpose: To update the 2000 ASCO guidelines on the role of bisphosphonates in women with breast cancer and address the subject of bone health in these women. Results: For patients with plain ...

Clinical outcomes and epidemiology of acute ischemic stroke in breast cancer patients admitted to U.S. hospital. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

In general, IV bisphosphonates are very well tolerated, and patients rarely require dose modification. In the comparative phase 3 trial of zoledronic acid and pamidronate in patients with breast ...

Researchers suggest bisphosphonate could potentially reduce the risk of colorectal cancer, but more randomized trials should be carried out to confirm their results, according to an Internal Medicine ...